Key Takeaways
- • CPAI trades at $52.40 USD with a price-to-earnings ratio of 30.46 and a dividend yield of 0.61% as of August 23, 2026, representing a 0.81% gain on the trading day.
- • Counterpoint Quantitative Equity ETF operates with a 0.75% expense ratio (as of February 1, 2026) and employs a rules-based, actively managed strategy using mathematical models to select U.S. equities across all market capitalizations.
- • The fund seeks long-term capital appreciation through a systematic, quantitative approach that identifies stocks with the highest predicted returns based on factor exposures, avoiding discretionary human judgment in stock selection.
- • Insider trading activity and holdings information for CPAI are tracked and publicly disclosed, providing transparency into institutional activity within the fund structure.
Summary
As of August 23, 2026, CPAI trades at $52.40 per share with a trailing price-to-earnings ratio of 30.46, indicating a premium valuation typical of growth-oriented quantitative strategies. The fund generated a 0.81% gain on the trading day. The dividend yield stands at 0.61%, reflecting a focus on capital appreciation rather than income generation. With an expense ratio of 0.75% as of February 1, 2026, CPAI's fee structure is competitively positioned within the actively managed quantitative ETF space, where model-based management and real-time rebalancing justify the costs relative to passive benchmarks.
The fund's insider trading disclosures and holdings information are publicly available and regularly updated, providing institutional investors with transparency into fund composition and material transactions. This accessibility allows sophisticated investors to monitor fund activity and make informed allocation decisions based on actual holdings and insider behavior patterns tracked through platforms like Quiver Quantitative.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.